Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...

The collaboration provides VedaBio access to essential CRISPR IP, accelerating the development of customised diagnostic ...

A study, published in the journal Frontiers in Genome Editing, outlines a method for editing single plant cells from sterile ...

The new system developed by Professor Chad Mirkin delivers CRISPR machinery more safely and effectively into cells.

It has long been understood that orchard automation is the key for industry’s profitability and sustainability. As part of ...

Researchers have unveiled a new type of nanostructure that dramatically improves CRISPR delivery. Called lipid nanoparticle ...

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading the developmental race).

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of ...

Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...

Researchers developed TESLA-seq, a CRISPR-based method to map DNA regions that regulate genes. By scanning thousands of ...

VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, Inc. for the use of select CRISPR-based ...